Arizona Liver Health

Today marks a global call to action: there are 8 billion reasons to act on obesity. More than 1 billion people live with obesity, and projections show that by 2035 half the world will be overweight or obese unless we change course. Obesity is a complex, chronic disease shaped by systems, environments, and inequities — and it significantly contributes to diabetes, cardiovascular disease, and other health burdens. At Arizona Liver Health | Arizona Clinical Trials, we’re proud to combine comprehensive patient care with cutting-edge clinical research in obesity/weight management and metabolic health. Our commitment includes: • Advancing evidence-based care pathways • Advanced metabolic and obesity-focused clinical research trials • Collaboration with referring providers to expand access to emerging therapeutics • High-quality trial execution supporting sponsors in the evolving obesity landscape Let’s work together to move the science forward. • Sponsors & CROs: Partner with ACT as your network of choice for obesity and metabolic clinical trials. Partners@azclinicaltrials.com • Referring Providers: Help connect patients to emerging therapies through our clinical research programs. referrals@azliver.com On World Obesity Day, we reaffirm our dedication to better outcomes, stronger evidence, and healthier lives — for all. #WorldObesityDay #8BillionReasons #ObesityCare #ClinicalTrials #HealthcareInnovation

Congratulations to Dr. Richard Manch – a Top Doctor in Arizona recognized for nearly 50 years of patient-centered care! As a founding member of Arizona Liver Health, he continues to expand access to liver care, lead clinical research, and drive innovative programs for at-risk and underserved populations. Read more: phoenixmag.com/2026/03/01/202… #TopDoctor #PatientCare #Hepatology #ArizonaHealthcare #LiverHealth

Our team had a fantastic time at Liver Connect last week! We’re proud to continually invest in education to better serve our patients, collaborate with fellow industry experts, and exchange meaningful insights that move liver care forward. A special shout out to Arizona Liver Health's Dr. Richard Manch for presenting and contributing his expertise to the conversation at the Round Table Discussion of Viral Hepatitis Cases. Grateful for the opportunity to learn, connect, and advance care together. #LiverConnect #continuingeducation #liverexperts

Arizona Clinical Trials (ACT) will be attending #SCOPE in Orlando! We support Phase 1 & Phase 2–4 trials with a 24-bed Phase 1 unit, in-house ACT Imaging, USP 800 research pharmacy, and rapid, adaptive recruitment across diverse populations. Contact Michelle Jones to meet! mjones@azclinicaltrials.com #scope #clinicalresearch #partnerwithus

As 2025 comes to a close, we want to extend our sincere gratitude for your continued support, collaboration, and partnership. Whether expanding access to care, driving innovative clinical research, or working together to elevate patient outcomes, your contributions have made a true impact this year. Wishing you a joyful holiday season filled with warmth and celebration, and a bright, healthy start to the new year. Warmest regards, Anita Kohli, MD, CEO & The Arizona Liver Health, Arizona Clinical Trials, & VEN Centers Team

🍂 Happy Thanksgiving from ALH, ACT, and VEN Centers! As we celebrate this season of gratitude, we want to take a moment to recognize the incredible people who make our work meaningful every day. We’re thankful for our dedicated team, whose passion and commitment drive everything we do. We’re grateful for our patients, who inspire us with their trust and resilience. And we deeply appreciate our partners, whose collaboration helps us advance health, research, and care. Wishing you and your loved ones a joyful, peaceful, and safe holiday filled with warmth, laughter, and cherished moments. Thank you for being a part of our journey!

Dylan Moore, RN, delivered an insightful presentation at the American Association for the Study of Liver Diseases (AASLD)® @AASLDtweets #TLM25, highlighting innovative strategies to improve access to hepatitis C care. His session, “Mobile HCV RNA Testing in Action: Point-of-Care Enabled Diagnosis and SVR Confirmation to Drive Field-Based HCV Elimination,” demonstrated how mobile point-of-care testing is transforming real-world HCV care delivery. Key takeaways included: • Same-day RNA Results Accelerate Treatment Start, Even Amid Medicaid Policy Barriers • Policy Reform and Funding are Essential to Enable Same-Day Treatment Initiation and Program Scale • Mobile POC RNA testing Reaches High-Risk, Hard-to-Reach Populations • Field Concordance Confirms Reliability of the Cepheid Platform VEN’s mobile testing approach is reshaping hepatitis C care by expanding access, accelerating diagnosis, and ensuring patients receive timely follow-up. Dylan closed with an inspiring reminder that we must all “Believe” to make the vision of hepatitis C elimination possible. We are inspired by Dylan’s leadership and remain committed to supporting innovative solutions that advance liver health across Arizona and beyond.

Happy National Nurse Practitioner Week to the dedicated NPs who make exceptional care possible. At Arizona Liver Health, Arizona Clinical Trials, and VEN Centers, we’re grateful to work with such exceptional professionals who lead with knowledge, empathy, and a relentless commitment to improving lives. Thank you for the care you provide, the trust you build, and the difference you make every single day. You are essential to our mission—and true champions for patient health.

Today, we recognize those who have served with dedication and courage. We extend our appreciation to all Veterans for their sacrifices in safeguarding our nation.

Arizona Liver Health has had an amazing few days at American Association for the Study of Liver Diseases (AASLD)'s #TLM25, exploring the latest innovations in liver disease diagnosis, treatment, and monitoring. Earlier Today, Dr. Anita Kohli had the chance to visit the @livivos , Inc booth and learn more about the LiverScope® and its growing clinical potential. She also received a LiverScope® MR-PDFF reading, providing valuable insight into the tool’s capabilities and applications. To learn more about LiverScope®, visit livivos.com/liverscope. If you’re attending @AASLDtweets #TLM25, we’d love to connect! Our team is available to discuss liver screening, clinical research opportunities, and collaborative initiatives. For meeting requests, please contact: Michelle Jones — mjones@azliver.com | +1 303-406-1735

We’re at Washington, DC for #tlm25! Meet with our ALH, ACT & VEN Centers team as we explore new opportunities in liver disease research and collaboration. Contact Michelle Jones to connect: mjones@azliver.com #AASLD2025 @AASLDtweets

Don’t miss Dylan Moore, RN, Director of VEN Centers, presenting at The American Association for the Study of Liver Diseases, The Liver Meeting® 2025 @AASLDtweets during the session: “Toward 2030: Collaborative Solutions for Hepatitis C Diagnosis, Care, and Elimination.” November 10, 2025 Convention Center — Ballroom C, Level 3 5:00 PM – 6:30 PM Dylan will highlight “Mobile HCV RNA Testing in Action: Point-of-Care Enabled Diagnosis and SVR Confirmation to Drive Field-Based HCV Elimination”, demonstrating how mobile, point-of-care models are helping expand access to Hepatitis C diagnosis and SVR confirmation. Attendees will learn how these practical, field-based approaches can help drive real-world HCV elimination efforts. The session will be moderated by: • Scott J. Cotler, MD, FAASLD — @LoyolaHealth • Gia Landry, MD, MPH — @LSUHealthNO Transplant Hepatologist & Clinical Network

Arizona Liver Health (ALH), Arizona Clinical Trials (ACT), and VEN Centers are pleased to announce participation in The Liver Meeting® 2025, hosted by the American Association for the Study of Liver Diseases @AASLDtweets this November. Our expert team — including Dr. Anita Kohli, Dr. Justin Reynolds, Dr. Richard Manch, Anne Moore, FNP-C, Angie Coste, FNP-C, Michelle Jones, and Dylan Moore, RN — will be on-site to share clinical insight, network with colleagues, and explore new opportunities to advance liver health and clinical research. This year’s meeting provides an important opportunity to discuss emerging developments in liver disease care and strengthen collaborations & partnerships that support continued innovation across hepatology. To connect or schedule a meeting during the event, please contact: Michelle Jones | mjones@azliver.com | +1 303-406-1735 We look forward to connecting at #AASLD25

We’re proud to announce the promotion of Enrique Topete to Regional Director of Research at Arizona Liver Health | Arizona Clinical Trials! Since joining in 2020, Enrique has led with excellence, driving growth, and launching our AMP Phase 1 Research Unit. Congrats, Enrique!